2023-08-10 16:03:34 ET
- AVITA Medical press release ( NASDAQ: RCEL ): Q2 GAAP EPS of -$0.41 misses by $0.10 .
- Revenue of $11.75M (+40.9% Y/Y) beats by $0.18M .
-
Financial Guidance
- Commercial revenue for the third quarter 2023 is expected to be in the range of $13 to $14 million
- Raising commercial revenue for the full year 2023 from $49 to $51 million to an expected range of $51 to $53 million
- Gross margin for the full year 2023 expected to be in the range of 83% to 85%
For further details see:
AVITA Medical GAAP EPS of -$0.41 misses by $0.10, revenue of $11.75M beats by $0.18M